Literature DB >> 28109740

First clinical isolation report of azole-resistant Aspergillus fumigatus with TR34/L98H-type mutation in Japan.

Takahito Toyotome1, Daisuke Hagiwara2, Hideyuki Kida3, Takahiro Ogi4, Akira Watanabe2, Terumi Wada3, Ryoichi Komatsu3, Katsuhiko Kamei2.   

Abstract

Recently, azole-resistant Aspergillus fumigatus containing a 34-bp or 46-bp tandem repeat in the promoter region of cyp51A combined with amino acid substitution(s) has appeared in the environment worldwide, including several Asian countries. In this study, we isolated the 34-bp tandem repeat-containing azole-resistant A. fumigatus strain OKH50 from a patient in Japan in May 2016. The patient had not been treated with medical azoles before the strain isolation, suggesting that the resistant property was acquired before infection. In addition, the patient had not traveled overseas. Our analysis of short tandem repeats of the strain indicates that the strain is strongly related to the 34-bp tandem repeat-containing isolates from European countries and Asia-Oceania countries but not to susceptible isolates from Japan, suggesting that the strain was introduced from overseas and might spread in Japan.
Copyright © 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aspergillus fumigatus; Azole; TR(34)/L98H; cyp51A

Mesh:

Substances:

Year:  2017        PMID: 28109740     DOI: 10.1016/j.jiac.2016.12.004

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.

Authors:  Laís Pontes; Caio Augusto Gualtieri Beraquet; Teppei Arai; Guilherme Leite Pigolli; Luzia Lyra; Akira Watanabe; Maria Luiza Moretti; Angélica Zaninelli Schreiber
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.